Cargando…
Overview on wearable sensors for the management of Parkinson’s disease
Parkinson’s disease (PD) is affecting about 1.2 million patients in Europe with a prevalence that is expected to have an exponential increment, in the next decades. This epidemiological evolution will be challenged by the low number of neurologists able to deliver expert care for PD. As PD is better...
Autores principales: | Moreau, Caroline, Rouaud, Tiphaine, Grabli, David, Benatru, Isabelle, Remy, Philippe, Marques, Ana-Raquel, Drapier, Sophie, Mariani, Louise-Laure, Roze, Emmanuel, Devos, David, Dupont, Gwendoline, Bereau, Matthieu, Fabbri, Margherita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622581/ https://www.ncbi.nlm.nih.gov/pubmed/37919332 http://dx.doi.org/10.1038/s41531-023-00585-y |
Ejemplares similares
-
Symptoms assessment and decision to treat patients with advanced Parkinson’s disease based on wearables data
por: Virbel-Fleischman, Clara, et al.
Publicado: (2023) -
Personality dimensions of patients can change during the course of parkinson’s disease
por: Boussac, Mathilde, et al.
Publicado: (2021) -
Could Sodium Chloride be an Environmental Trigger for Immune-Mediated Diseases? An Overview of the Experimental and Clinical Evidence
por: Toussirot, Eric, et al.
Publicado: (2018) -
Subthalamic Nucleus Stimulation Affects Theory of Mind Network: A PET Study in Parkinson's Disease
por: Péron, Julie, et al.
Publicado: (2010) -
Optimization of cytotoxic activity of Nocardia sp culture broths using a design of experiments
por: Noël, Alba, et al.
Publicado: (2020)